Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  9, 575 - 581 (2003)
Published online: 7 April 2003; | doi:10.1038/nm849

The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion

Lee-Wei Chen1, 3, Laurence Egan2, Zhi-Wei Li1, Florian R. Greten1, Martin F. Kagnoff2 & Michael Karin1

1  Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, University of California, San Diego, California, USA

2  Laboratory of Mucosal Immunology, Department of Medicine, University of California, San Diego, California, USA

3  Department of Surgery, Kaohsiung Veterans General Hospital, National Yang-Ming Medical University, Taipei, Republic of China

Correspondence should be addressed to Michael Karin karinoffice@ucsd.edu
We studied the role of NF-kappaB in acute inflammation caused by gut ischemia-reperfusion through selective ablation of IkappaB kinase (IKK)-beta, the catalytic subunit of IKK that is essential for NF-kappaB activation. Ablation of IKK-beta in enterocytes prevented the systemic inflammatory response, which culminates in multiple organ dysfunction syndrome (MODS) that is normally triggered by gut ischemia-reperfusion. IKK-beta removal from enterocytes, however, also resulted in severe apoptotic damage to the reperfused intestinal mucosa. These results show the dual function of the NF-kappaB system, which is responsible for both tissue protection and systemic inflammation, and underscore the caution that should be exerted in using NF-kappaB and IKK inhibitors.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
MAN THE BARRIER! STRATEGIC DEFENCES IN THE INTESTINAL MUCOSA
Nature Reviews Immunology Review Article (01 Oct 2001)
Genetic regulation of host responses to Salmonella infection in mice
Genes and Immunity Reviews (01 Nov 2002)

NEWS AND VIEWS
Yersinia lead SUMO attack
Nature Medicine News and Views (01 Jan 2001)
Corticosteroids and cardioprotection
Nature Medicine News and Views (01 May 2002)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy